PMID- 36621148 OWN - NLM STAT- MEDLINE DCOM- 20230203 LR - 20231213 IS - 1090-2104 (Electronic) IS - 0006-291X (Linking) VI - 644 DP - 2023 Feb 12 TI - CypD-mediated mitochondrial dysfunction contributes to titanium ion-induced MC3T3-E1 cell injury. PG - 15-24 LID - S0006-291X(22)01767-3 [pii] LID - 10.1016/j.bbrc.2022.12.088 [doi] AB - Titanium (Ti) ion can stimulate osteoblast apoptosis and therefore have a high potential to play a negative role in the aseptic loosening of implants. Mitochondrial abnormalities are closely related to osteoblast dysfunction. However, the mitochondrial molecular mechanism of Ti ion induced osteoblastic cell apoptosis is still unclear. This study investigated in vitro mitochondrial oxidative stress (mtROS) mediated mitochondrial dysfunction involved in Ti ion-induced apoptosis of murine MC3T3-E1 osteoblastic cells. In addition to reducing mitochondrial membrane potential (MMP) and decreasing adenosine triglyceride production, exposure to Ti ions increased mitochondrial oxidative stress. Moreover, mitochondrial abnormalities significantly contributed to Ti ion induction of osteoblastic cellular apoptosis. A mitochondria-specific antioxidant, mitoquinone (MitoQ), alleviated Ti ion-induced mitochondrial dysfunction and apoptosis in osteoblastic cells, indicating that Ti ion mainly induces mitochondrial oxidative stress to produce a cytotoxic effect on osteoblasts. Here we show that the primary regulator of mitochondrial permeability transition pore (mPTP), cyclophilin D (CypD), is involved in mitochondrial dysfunction and osteoblast cell apoptosis induced by Ti ion. Overexpression of CypD exacerbates osteoblast apoptosis and impairs osteogenic function. Moreover, detrimental effects of CypD were rescued by cyclosporin A (CsA), an inhibitor of CypD, which shows its protective effect on mitochondrial and osteogenic osteoblast functions. Based on new insights into the mitochondrial mechanisms underlying Ti ion-induced apoptosis of osteoblastic cells, the findings of this study lay the foundation for the clinical use of CypD inhibitors to prevent or treat implant failure. CI - Copyright (c) 2022 Elsevier Inc. All rights reserved. FAU - Mao, Yixin AU - Mao Y AD - Department of Prosthodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China; Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China; Laboratory for Myology, Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam (VUA), Amsterdam Movement Sciences, Amsterdam, 1081, HZ, Netherlands. FAU - Chen, Yang AU - Chen Y AD - Department of Prosthodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China; Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China. FAU - Cai, Wenjin AU - Cai W AD - Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, 310000, China. FAU - Jiang, Wanying AU - Jiang W AD - Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China. FAU - Sun, Xiaoyu AU - Sun X AD - Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China. FAU - Zeng, Jun AU - Zeng J AD - Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China. FAU - Wang, Hongning AU - Wang H AD - Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China. FAU - Wang, Xia AU - Wang X AD - Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China. FAU - Dong, Wenmei AU - Dong W AD - Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China. FAU - Ma, Jianfeng AU - Ma J AD - Department of Prosthodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China; Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China. FAU - Jaspers, Richard T AU - Jaspers RT AD - Laboratory for Myology, Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam (VUA), Amsterdam Movement Sciences, Amsterdam, 1081, HZ, Netherlands. FAU - Huang, Shengbin AU - Huang S AD - Department of Prosthodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China; Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, 325027, China. Electronic address: huangsb003@wmu.edu.cn. FAU - Wu, Gang AU - Wu G AD - Department of Oral and Maxillofacial Surgery/Pathology, Amsterdam UMC and Academic Centre for Dentistry Amsterdam (ACTA), Vrije Universiteit Amsterdam (VUA), Amsterdam Movement Science, Amsterdam, the Netherlands; Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam (UvA), Vrije Universiteit Amsterdam (VU), Amsterdam, the Netherlands. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20221231 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Peptidyl-Prolyl Isomerase F) RN - D1JT611TNE (Titanium) RN - EC 5.2.1.- (Cyclophilins) RN - 83HN0GTJ6D (Cyclosporine) RN - 0 (Mitochondrial Membrane Transport Proteins) SB - IM MH - Mice MH - Animals MH - Peptidyl-Prolyl Isomerase F/metabolism MH - *Titanium/pharmacology MH - *Oxidative Stress MH - Cyclophilins/metabolism MH - Cyclosporine/pharmacology MH - Mitochondria/metabolism MH - Mitochondrial Membrane Transport Proteins/metabolism OTO - NOTNLM OT - Apoptosis OT - Cyclophilin D OT - Mitochondrial reactive oxygen species OT - Osteoblasts OT - Titanium ion COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/01/10 06:00 MHDA- 2023/02/04 06:00 CRDT- 2023/01/09 04:35 PHST- 2022/11/17 00:00 [received] PHST- 2022/11/23 00:00 [revised] PHST- 2022/12/30 00:00 [accepted] PHST- 2023/01/10 06:00 [pubmed] PHST- 2023/02/04 06:00 [medline] PHST- 2023/01/09 04:35 [entrez] AID - S0006-291X(22)01767-3 [pii] AID - 10.1016/j.bbrc.2022.12.088 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2023 Feb 12;644:15-24. doi: 10.1016/j.bbrc.2022.12.088. Epub 2022 Dec 31.